Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 7/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9802008 | 1.00 | SLC6A2 (0.33) | SLC6A2SLC6A4SLC6A3ALDH1A1OPRM1 | |
| SCHEMBL8316585 | 0.97 | — | — | |
| SCHEMBL31058313 | 0.90 | — | — | |
| SCHEMBL28821044 | 0.75 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3ALDH1A1OPRM1 | |
| SCHEMBL28414632 | 0.73 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL305703 | 0.73 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL27433030 | 0.71 | TAS2R38 (0.30) | — | |
| SCHEMBL6823771 | 0.71 | MEN1 (0.33) | ALDH1A1 | |
| SCHEMBL5417347 | 0.69 | — | — | |
| SCHEMBL9801157 | 0.69 | SLC6A2 (0.31) | SLC6A2SLC6A4SLC6A3OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023168218-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-09-07 | — | — | WO | claimed |
| EP-4208485-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC POLYMERIZATION OF CONJUGATED DIENES AND LIQUID POLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-07-12 | — | — | EP | claimed |
| CN-115554812-A | Accelerant and absorbent for carbon dioxide absorbent and method for reducing carbon dioxide emission | 中国石油化工股份有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-110227161-A | CNS inhibitor is combined with opioid for the purposes in endoscopy | 江苏恒瑞医药股份有限公司 | 2019-09-13 | — | — | CN | claimed |
| US-9562014-B2 | (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof | MALLINCKRODT LLC (US) | 2017-02-07 | — | — | US | claimed |
| US-20170029432-A1 | (+)-MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF | MALLINCKRODT ENTERPRISES LLC | 2017-02-02 | — | — | US | claimed |
| EP-2593095-A1 | (+)-MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF | Mallinckrodt LLC (US) | 2013-05-22 | — | — | EP | claimed |
| CN-102766247-A | Rigid polyurethane/polyvinyl chloride composite foam plastic and preparation method thereof | SHANGHAI CHLOR ALKALI CHEMICAL | 2012-11-07 | — | — | CN | claimed |
| EP-2059333-B1 | AMINE AQUEOUS SOLUTION FOR FORMING AN ACTIVE LAYER OF POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE AND PREPARATION METHOD OF POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE USING THE SAME | WOONGJINCOWAY CO LTD (KR) | 2012-10-31 | — | — | EP | claimed |
| CN-101511459-B | Amine aqueous solution for forming an active layer of polyamide reverse osmosis composite membrane, polyamide reverse osmosis composite membrane prepared thereby, and preparation method thereof | WOONGJIN COWAY CO LTD | 2012-08-08 | — | — | CN | claimed |
| WO-2012008984-A1 | (+)-MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF | MALLINCKRODT LLC (US) | 2012-01-19 | — | — | WO | claimed |
| US-20120003387-A1 | AMINE AQUEOUS SOLUTION FOR FORMING AN ACTIVE LAYER OF POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE, POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE PREPARED THEREBY, AND PREPARATION METHOD THEREOF | KIM YOUN-KOOK (KR) | 2012-01-05 | — | — | US | claimed |
| JP-4827968-B2 | — | — | 2011-11-30 | — | — | JP | claimed |
| US-20110136845-A1 | (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof | MALLINCKRODT INC. (US) | 2011-06-09 | — | — | US | claimed |
| US-20100181250-A1 | AMINE AQUEOUS SOLUTION FOR FORMING AN ACTIVE LAYER OF POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE, POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE PREPARED THEREBY, AND PREPARATION METHOD THEREOF | WOONGJINCOWAY CO., LTD. (KR) | 2010-07-22 | — | — | US | claimed |
| CN-101511459-A | Amine aqueous solution for forming an active layer of polyamide reverse osmosis composite membrane, polyamide reverse osmosis composite membrane prepared thereby, and preparation method thereof | WOONGJIN COWAY CO LTD (KR) | 2009-08-19 | — | — | CN | claimed |
| EP-2059333-A1 | AMINE AQUEOUS SOLUTION FOR FORMING AN ACTIVE LAYER OF POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE, POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE PREPARED THEREBY, AND PREPARATION METHOD THEREOF | Woongjincoway Co, Ltd. (KR) | 2009-05-20 | — | — | EP | claimed |
| WO-2008030006-A1 | AMINE AQUEOUS SOLUTION FOR FORMING AN ACTIVE LAYER OF POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE, POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE PREPARED THEREBY, AND PREPARATION METHOD THEREOF | WOONGJINCOWAY CO, LTD, . (KR) | 2008-03-13 | — | — | WO | claimed |
| CN-115554812-A | Accelerant and absorbent for carbon dioxide absorbent and method for reducing carbon dioxide emission | 中国石油化工股份有限公司 | 2023-01-03 | — | — | CN | disclosed |
| US-4239504-A | Free base amino alcohols as electrostatic precipitator efficiency enhancers | BETZ LABORATORIES, INC. (US) | 1980-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029432-A1 | (+)-MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF | TLR9, TLR3, TLR7 | SLC6A2 87/4885SLC6A4 83/4885SLC6A3 134/4885 |
| US-20110136845-A1 | (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof | TLR9, TLR3, TLR7 | SLC6A2 87/4885SLC6A4 83/4885SLC6A3 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.